cialized immunosuppressive regimens tailored for pediatric patients to improve long-term outcomes. What ethical issues are covered regarding living donor liver transplantation in 'Transplantation of the Liver 3e'? The book examin
sive Strategies Corticosteroids: Reduce inflammation. Calcineurin Inhibitors: Tacrolimus, cyclosporine inhibit T-cell activation. Antimetabolites: Azathioprine, mycophenolate mofetil suppress lymphocyt
n graft-versus-tumor effects. Common agents include busulfan, cyclophosphamide, fludarabine, and melphalan. Graft Collection and Handling Sources of Stem Cells Bone Marrow: Collected via aspiration; lower GVHD risk. Peripheral Blood Stem Ce
vital subspecialties that significantly impact patient survival and quality of life. Their success relies on multidisciplinary collaboration, meticulous patient selection, advanced surgical techniques, a
phoblastic Leukemia (ALL): Particularly in relapsed or refractory cases. Chronic Myeloid Leukemia (CML): Historically, less common now due to targeted therapies, but still relevant for advanced or resistant cases. Multiple Myeloma: Autologous BMT is standard for eligible patients. Lymp
ts and Innovations in Bone Marrow Transplantation The field of hematology continually advances to improve outcomes and reduce complications associated with BMT. Reduced-Intensity Conditioning (RIC) Traditional conditioning regimens are intensive, but RIC uses lower doses of chemotherapy and r
